US panel recommends low dose aspirin to prevent cardiovascular disease and colorectal cancerBMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i2061 (Published 12 April 2016) Cite this as: BMJ 2016;352:i2061
- Michael McCarthy
The US Preventive Services Task Force has recommended low dose aspirin for the primary prevention of cardiovascular disease and colorectal cancer in adults aged 50 to 59 years who are at high risk of cardiovascular disease.
The recommendations apply to adults who have a 10% or greater 10 year risk of a cardiovascular event, are not at risk of gastrointestinal bleeding, have a life expectancy of at least 10 years, and are willing to take low dose aspirin daily for at least 10 years. The recommendations and accompanying evidence reviews appeared in Annals of Internal Medicine on 12 April.1 2 3 4
Cardiovascular disease is responsible for more than half of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial